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The Center of Excellence in Livestock Diseases and Human Health provides much needed support for some
important research in the CVM. Funds are used to help support research by productive investigators with a
track record of extramural funding. New investigators with projects having the most potential for securing
extramural support and who can also obtain some departmental cost-sharing are also very carefully considered
for support. In selected cases the COE funds are invested in some "start-up funds to enhance and accelerate
the research of new faculty with promising research programs.
The COE funding has been very successful in assisting some of our new faculty in submitting grants and
successfully competing for outside funding. This support has helped cement ties with The Thompson Cancer
Survival Center and their funding of research projects with Dr. Donita Frazier and Dr. Kevin Hahn.
The concept of the COE stimulates collaboration between a multitude of different researchers and encourages
sharing of equipment, ideas and many resources. Successful projects by researchers such as Drs. Linda
Munson, Erby Wilkinson, Philip Bochsler, Doug Dawson and David Dean were all strengthened by initial COE
support. These successful grants from outside funding agencies have included NIH, USDA, U.S. Air Force,
EPA, as well as private corporations such as the American Cyanamid Company and the Upjohn Company.
Several patents by Drs. Jack Oliver and Leon Potgieter have also resulted from projects initially funded, in part,
by the COE.
In these times of declining outside funding and increasing competition, the COE funds have also been used to
bridge any gap in funding that some of our established researchers may temporarily encounter.
Through the Venture Grant Program, the COE also helps fund a limited number of promising pilot projects
submitted by residents and graduate students.
A significant part of the continued growth and success of the College of Veterinary Medicine research program
can be attributed to COE support in its many forms. Despite the financial hardships in the last two budgetary
years, the CVM has managed to proceed with most of its plans due to careful fiscal control and COE support.
Continued support from the COE will help us expand our research and continue to provide answers to some of
the myriad of disease problems. Focusing on a few selected areas of research has also stimulated collaboration
and sharing of ideas, equipment and other resources. The spirit of cooperation existing within our College is
greatly enhanced by the support offered through the COE and the democratic and open process through which
support is given.
The COE is a significant factor in the success of this College and, to my mind, is an excellent example of
minimal expenditure for maximum return. Continued support will help to maintain and, hopefully, expand our
strong research foundation.

GOALS

Goal 1:

To improve the quality of human life through better animal health.

Goal 2:

To augment livestock disease research capabilities in the Institute of
Agriculture.

Goal 3:

To identify and characterize animal diseases that are analogous to human
diseases.

Goal 4:

To study these animal models for better understanding of human disease.

GoalS:

To understand the pathogenesis an characterize the causative agents of
common disease important to Tennessee.

Goal 6:

To improve the capabilities of the College of Veterinary Medicine, the
College of Agriculture and the Agricultural Experiment Station to deal with
these diseases.

Goal 7:

To improve facilities to enable the College of Veterinary Medicine to study
more effective infectious and toxic diseases affecting animals.

GoalS:

To disseminate through the Extension Service the practical information
required to reduce the incidence of livestock diseases.

Goal 9:

To develop new strategies for the prevention of disease.

Goal 10:

To enhance the College's ability to recruit superior faculty and graduate
students and to attract more external funding for research.

Goal 11:

To improve facilities an expertise in order to provide improved research
training.

Goal 12:

To develop innovative approaches to the treatment of human disease.
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I. PROGRAMMATIC REPORT
LA

PERSONNEL CHANGES

LA 1. Personnel Additions

Dr. Charmi Mendis-Handagama and Dr. Teresa Rowles, who hold
appointments in the Department of Animal Science are being added this year to
the Center of Excellence Faculty. Dr. Mendis-Handagama received her D.V.M.
from the University of Sri Lanka, Peradeniya and her Ph.D. from Monash
University, Melbourne, Australia. Dr. Teresa Rowles received her D.V.M. from
The University of Tennessee and her Ph.D. from Texas A&M University.
1.A.2. COE Members Leaving
Dr. Clinton Lothrop resigned from the University in February 1992 to
accept a position in the Scott-Ritchey Research Center at Auburn University. He
will maintain close ties with the college in collaboration with both the Growth
Factor and Oncology groups.
Dr. Jeanne Maddux resigned in May 1992 to move to Alaska.
1.A.3. Graduate and DVM Student Opportunities
With the transition to a four-year, semester system, the College has been
able to initiate a program to provide veterinary students experience in animal
model-based biomedical research. This 12-week summer program focuses on first
and second year veterinary students who have maintained a high academic
standing and who have shown an interest in research. This experience should
accelerate completion of their Ph.D. programs.
The Department of Comparative Medicine, UT/Memphis, in collaboration
with the Comparative and Experimental Medicine Program is seeking to establish
a postdoctoral graduate program in laboratory animal/comparative medicine.
This program will be for the purpose of preparing graduate veterinarians to
become productive members of the biomedical research community as specialists
in laboratory animal medicine, and to attain board certification in the American
College of Laboratory Animal Medicine.
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RENOVATION OF FACILITIES AND EXPANSION OF SERVICES

1.B.1 Animal Facilities Improvements

With support from the Center of Excellence, Dr. Edward Schroeder,
Laboratory Animal Veterinarian was able to apply for, and receive funding from
the National Institutes of Health, for improving the use of space by incorporating
isolation technology and labor saving equipment. The improvements have
allowed a measure of flexibility and efficiency and has provided a higher level of
animal care. With newly funded faculty coming into the college, as well as the
onset of new faculty positions, these renovations have made it possible to have a
variety of rodent species in special environments. In addition, the new equipment
has improved cleaning methods and reduced the risk of cross contamination when
cages are changed.
1.B.2 Library Services Added

The library has instituted several new services that impact on agriculture
and veterinary medicine. With the addition of AGRICOLA, the largest and most
comprehensive source of U. S. agricultural information, and CAB ABSTRACTS,
an International research database of agricultural information and the source of
information for veterinary mediCine, human nutrition, developing countries,
leisure, recreation, and tourism, faculty have the major indexes for agriculture and
veterinary medicine available for searches anytime.
1.C.

SPECIAL MATERIALS AND EQUIPMENT

A protein microsequenator, a DNA synthesizer, an upgraded HPLC, and a
Doppler ultrasound attachment were purchased for college-wide use. Individual
departments were also allocated funds for specific equipment items (e.g., Queue
incubator, electroelution unit; Gene amplification polymerase system and gel
dryer; and Coulter counter) for individual and department-wide use.
1.D

MAJOR PROGRAMMATIC ACTIVITY

1.D.1 Research '92

Research '92 was the college's 5th annual presentation of current research.
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Through the UT Office of Research and Technology Development, the college
was awarded a Hertel Grant, to partially sponsor the program. The first day of
activities entailed the Distinguished Lecture Series which was presented at the
University Center on the Main Campus followed by a Reception and Poster
presentation. On day two, the program returned to the Veterinary Teaching
Hospital with 11 presentations by senior and junior faculty, graduate students, and
residents. The exposure provided campus-wide attention to many of the excellent
research activities taking place at the College of Veterinary Medicine, and
brought enhanced interaction among various members of the campus and off
campus biomedical sciences community and College of Veterinary Medicine
faculty.
Additionally, Research '92 provided an easy way for potential graduate
students to learn of research activities within the College of Veterinary Medicine
that may be of interest to them, and provided positive publicity for research at the
College and University.

l.D.2 Minority Recruitment
Because of a genuine interest by faculty, students, and staff, more minority
applicants are giving consideration to the various programs within the college.
Specific interest areas are the DVM program, graduate student program, and
residency programs in both Rural and Urban Practices.
With the addition of teachers to the Minority High School Apprentice
Program sponsored by the National Institutes of Health, we are already
experiencing extra incentive and visibility and more interest in veterinary medicine
and the biomedical sciences from students.
The college has added 10 students from the Upward Bound Program to its
summer science experience. This six-week program includes students from
different states.

l.D.3 Collaborative Research Projects
With recent notification from the NIH National Eye Institute of funding
for his competitive renewal entitled Immunopathological Mechanisms in Herpetic

Stromal Keratitis, Dr. Barry Rouse in collaboration with Dr. Deborah Distephano
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in the Department of Ophthalmology at The University of Tennessee,
Chattanooga, will continue to further define the role of CD4 + T lymphocytes in
Herpes simplex virus (HSK) as well as the part played by CD8 + T cells at
modulating the HSK reaction.
A collaborative project with Oak Ridge on which Dr. Erby Wilkinson
serves as principal investigator is entitled The Immunobiology of the Scurfy Mouse
and relates to cellular immunology and the role of the microenvironment of the
thymus in the production, selection, and export of functional T cells. The Scurfy

(sf) mutant mouse forms an interesting model for such studies. Scurfy mice
develop a severe x-linked lymphoproliferative disease that primarily affects skin
and lymphoid organs and is an early cause of death. Several pieces of evidence
implicate the thymus in development of the scurfy phenotype, and investigations
are underway to better understand the pathogenesis of this disease. Such data is
likely to enhance the investigator's understanding of the role of the thymus in T
cell differentiation. Dr. Barry Rouse is also a collaborator on the Scurfy mouse
project.
In another collaborative effort, Dr. Hildegard Schuller is now embarking
on a major venture as evidenced by her recent submission of an NCI Program
Project. This $7 million project encompasses two medical schools within the
United States and one outside the country, and three faculty members in the
college. The project will link basic and clinical approaches to targeting mitogenic
signal transduction pathways for the development of novel means of lung cancer
therapy. While most lung cancer types generally do not respond to conventional
radio- and chemotherapy, small cell cancer, a highly malignant neuroendocrine
form of the disease, often demonstrates an initial response. However, in most
cases, multi-drug-resistance develops, thus rendering the mortality rate of lung
cancer in general at 90%. Preliminary data strongly suggests that B859-35 and
similar agents may inhibit the continuous proliferation of lung cancers whose
proliferative activity depends on Ca2 + /calmodulin/protein kinase C mediated
signal transduction loops. Dr. Sch filler is a leading researcher in the field of basic
lung cancer research at both a national and international level. Funding of this
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project would help establish an oncology center within the College of Veterinary
Medicine.
Dr. Terry Schultz in collaboration with Dr. Mark Kot is examining ways of
monitoring and modeling biological chaos using an environmentally controlled
microbial system. A major effort is underway to examine the usefulness of
double-Monad systems. This unique blend of experimental and modeling science
in the past two years has been funded by the National Science Foundation and is
currently being funded by the Department of Energy.
FETAX is fast becoming recognized as the premier non-mammalian system
for the study of toxicant effects on development. A standard guide for conducting
the assay has been published by the American Society for Testing and Materials.
FETAX is now required for evaluation of sediment toxicity in the state of
Washington. Dr. Doug Dawson is involved in an interlaboratory validation study
with researchers from Oklahoma State University, the U. S. Army, the University
of Maryland, Stover Biometric, and other laboratories around the country. Upon
completion of the project, the EPA is expected to require FETAX testing in the
process of pesticide registration.
l.D.4 Dissemination of Information
Research at the college has been highlighted by the media nationally,
statewide, and locally during the past year. CNN featured ongoing research
related to production of the red panda, a threatened species. The features aired
several times in June as part of the CNN evening news, then was aired as a
segment in a half hour CNN series called "Science and Technology Week." A
public television series called "The Gentle Doctor" spent two days at the college
in taping a segment for the nationally broadcast series about veterinary medicine.
The feature will air during the 1992-93 seasons. Veterinary research is routinely
featured on Tennessee television news programs in Knoxville. In addition, a
television station from Nashville produced a lengthy news feature on the college
in 1992. Newspaper articles have covered a wide range of research news and
profiles of college faculty. Topics have included cancer research, toxic agents
affecting cattle, auto-immune disease, as well as features on a new department
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head and on other members of the faculty. Members of the Infectious Diseases
and Population Medicine Group continue to work through Extension Service
veterinarians to transfer the latest information on livestock diseases to the public.
The college is also featured regularly in UT publications, including UT Agriculture,
a magazine distributed to the Tennessee agricultural community and alumni; UT
Alumnus, sent to graduates and contributors of the university statewide;
Torchbearer, a UTK alumni publication; and Context, the UTK faculty and staff

newspaper. Additionally, the college disseminates information through its own
newsletter, Veterinary News, sent to Tennessee veterinarians and college alumni,
and through other informational brochures for veterinarians and the general
public. Information is also dispersed through the UT Extension Service
veterinarians. They have regular newspaper columns statewide and respond to a
variety of questions from Tennessee farmers and pet owners. They contribute to
an extension service newsletter called Veterinary Topics, which is distributed to
Tennessee veterinarians.
I.D.S Major Research Areas
GROWTH FACTORS GROUP

The major emphasis of Dr. Robert Shull's research program is to treat
dogs with mucopolysaccharidosis I by insertion of the gene for the deficient
enzyme a-L-iduronidase into their bone marrow cells. Canine iduronidase has
been purified, sequenced, and the gene cloned. Retroviral vector technology is
being used to insert the gene into cultured bone marrow stem cells which will
then be returned to the dog. A major effort is being made to use various novel
stem cell factors as c-kit ligand to stimulate stem cells to divide and incorporate
the new gene. If this is successful, the canine experiments may pave the way for
replacement gene therapy in children with similar diseases. They are also
planning on investigating the effects of direct injections of recombinant enzyme
into MPS I-affected dogs. Notification from NIH that their competitive renewal
has been funded assures Dr. Shull's collaboration with scientists at UCLA and
USC in Los Angeles for at least S more years.
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One of Dr. Linda Munson's long range research goals is to understand the
regulation of placental growth by endogenous growth factors. Her proposed
research investigates the role of transforming growth factors (TGFs) in controlling
proliferation and adhesion of trophoblastic and endometrial epithelial cells at the
maternal/fetal interface in developing bovine placentas. She is exploring the
possibility that a novel mechanism of communication occurs between fetal and
maternal tissues in the developing placenta called "juxtacrine."
The research performed in Dr. James Godkin's laboratory focuses on the
fetal-maternal interactions that are responsible for the maintenance of pregnancy
and the growth and development of the embryo. His work has concentrated on
proteins produced by fetal placental membranes. Most recent studies have
centered on vitamin A (retinoid)-associated proteins. It has been recognized for
over 50 years that vitamin A (retinol) is essential for reproduction. Recently a
natural vitamin A metabolite, retinoic acid (RA), has been identified as a
morphogen that dictates pattern formation in developing embryos. The action of
retinoids (vitamin A and its analogs) is believed to be mediated by a
plasmalextracellular transport protein, retinol-binding protein (RBP), two
intracellular binding proteins (CRBP, CRABP), and RA nuclear receptors
(RAR's). They have recently discovered that all of the placental extraembryonic
membranes and the uterus synthesize RBP. They are currently investigating the
molecular expression of the retinoid associated proteins in developing embryos
and maternal uterine tissues.
Cloning the gene for thrombopoietin (TPO) remains one of the major
goals of Dr. Ted McDonald. The role of TPO in regulation of thrombocytopoiesis
has recently become clearer and the use of TPO in treating patients with platelet
production disorders appears appropriate. During the last year, they have made
progress in cloning the gene for thrombopoietin by adding to the amino acid
sequence of the molecule and gained helpful insight into TPO's stability in various
aqueous solutions.
During the last year, they have used TPO as a radioprotective agent for
treating mice after whole-body irradiation. The results show that irradiated mice
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treated with TPO had higher platelet counts and increased %35 S incorporation
into platelets than did irradiated controls. These results suggest that TPO therapy
will modulate the severe thrombocytopenia that occurs in irradiation-induced
bone marrow suppression and indicates great clinical promise for this regulatory
factor.

ONCOLOGY GROUP
Dr. Mark Miller, in collaboration with Dr. Hildegard Schiiller, has been
studying the effects of cigarette smoking as a causative agent in lung cancer. They
have been using an animal model system, developed at The University of
Tennessee by Dr. Schiiller, to explore the molecular mechanism of cancer
causation with the ultimate goal of trying to develop novel anti-cancer drugs that
would be targeted to the specific genetic lesions responsible for tumor growth.
The animal model they have employed involves the treatment of hamsters
with nitrosamines, a class of carcinogenic compounds that are prevalent in
cigarette smoke, under conditions of increased oxygen levels. This treatment
regimen results in the formation of a specific type of lung cancer that exhibits
neuroendocrine features. This animal model is the only known model that
produces neuroendocrine lung tumors. Their results have shown that the hamster
tumors show the same types of genetic lesions as found in human small cell lung
cancers. They will also continue to explore ways to inhibit tumor growth based on
their findings of enhanced gene expression in these tumors. They have also been
studying the potential effects of cigarette smoking combined with ethanol
consumption during pregnancy. These studies should provide further information
on environmental risk factors for lung cancer formation, and emphasize the
potential risks to the fetus of exposure to ethanol and potential carcinogenic
agents found in cigarette smoke.
Recent efforts of the Predictive Toxicity Program has centered studies of
aryl alcohols and aldehydes. Specifically, Dr. Terry Schultz's laboratory has
identified that addition of one or more aromatic rings to the carbon atom
attached to a hydroxyl group is a sufficient alteration in molecular structure to
cause a change in mechanism of toxic action. They have completed the
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development of the gas-tight lethality assay. Moreover, they have tested large
numbers of electrophilic aldehydes. Comparing relative toxicities for aldehydes in
the gas-tight assay with those in the more conventional growth assay revealed that
the presence of pep tides and nucleic acids in the medium used in the growth assay
modulates the toxic response of the direct-acting electrophiles by acting as
nucleophiles. These findings have been validated by analyses of data from other
test systems and go a long way in explaining the disparities in the literature on
aldehyde toxicity.
Present work by Dr. Doug Dawson involves basic research into the way
chemical mixtures interact to induce malformations (Le., birth defects) in
developing vertebrate animals. This research has led to the development of a
technique which can be applied to the fields of aquatic and developmental
toxicology. Work is also underway examining a series of carboxylic acids, in order
to determine the compounds that have the greatest potential to cause birth
defects. This work leads to the development of mathematical equations which can
then be used to predict the potential hazard for any structurally similar chemical,
without having to test the chemical. Therefore, the methodology has the potential
to reduce the numbers of animals needed in toxicological testing.
INFECTIOUS DISEASES AND POPULATION MEDICINE

Dr. Steve Oliver's studies from last year have identified suitable
microbiological procedures for identification of Streptococcus uberis and other
Streptococcus species. He recently reported on a new technique to differentiate
Strep. uberis from the closely related Strep. parauberis by polymerase chain
reaction and restriction fragment length polymorphism analysis of 16S ribosomal
DNA This technique will be of considerable importance in subsequent studies on

the epidemiology and pathogenesis of Strep. uberis mastitis. An identification
scheme for Streptococcus and Enterococcus species was also developed based on
the same analysis. Procedures are now available for genetic identification of
Streptococcus and Enterococcus species of bovine origin. Dr. Oliver has recently
received funds from The Upjohn Company to work on a study entitled
Immunization of Dairy Cows Against Strepococcus uberis.
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A major challenge in both human and veterinary medicine today is the
development of targeted methods to specifically interrupt virus infections that are
persistent within the host and lead to chronic diseases. Coronaviruses are
ubiquitous in nature causing a wide variety of disease in animals. Dr. David
Brian's laboratory is the first in the world to report the existence of an intraleader
open reading frame and its development (selection) during persistent infection.
His objective is to examine in detail how variant leader structures regulate
translation rates. In the last two years, two other virus families, the toroviruses (a
cause of gastroenteritis in calves, horses, and possibly humans) and arteriviruses (a
cause of equine arteritis) have been placed along with coronaviruses into a
coronavirus superfamily. These all share a common strategy of RNA
transcription, and possibly replication. Thus, what they describe as mechanisms of
coronavirus persistent infection may be pertinent to these other families as well.
Infection with bovine viral diarrhea virus (BVDV) results in tremendous
losses to cattle farmers annually. The major envelope protein of BVDV is the
only virally-encoded polypeptide consistently precipitated with BVDV antisera,
and is the target for neutralizing antibodies. Dr. Leon Potgieter's laboratory has
cloned and sequenced the genomic sequence encoding this glycoprotein from a
noncytopathic strain of BVDV. Additionally, they have subcloned this viral
sequence into a baculovirus expression system that provides for production of
large amounts of properly processed viral protein. They hope to gain insight into
the immune response induced by this important viral agent, as well as evaluate
the potential usefulness of a recombinant vaccine consisting of BVDV structural
proteins. Dr. Potgieter's goal is to use the viral protein produced in this system to
define the immunogenicity of the major envelope protein and use it for
immunization of cattle against this serious infection.
Recent studies have determined potential toxicity of individual alkaloids
that are present in fescue grass infected with the fungus Acremonium
coenophialum. Dr. Jack Oliver's laboratory has been the first to show, in cattle,
biological activity associated with three of the five major alkaloid types found in
toxic fescue. Results of these studies indicate that the various alkaloid types that
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are present in toxic fescue, have greater or lesser effects on specific tissue
receptors that control organ function. Thus, it appears it will be difficult to
develop a singular chemical agent to block all of the various effects of toxic fescue
alkaloids.
Other studies have led to the development of a model system in cattle that
allows the effects of individual alkaloids to be studied over a period of time.
Alkaloids are constantly administered to animals by a miniature pumping device
that is implanted under the skin. This system mimics the natural situation where
cattle consume the toxic alkaloids while grazing, but has the advantage of looking
at toxicity caused by a single alkaloid, where the concentration and amount of
alkaloid that the animal actually is exposed to is known.
Because of the difficulty of controlling the toxic fescue condition in cattle
with drugs, Dr. Oliver's research group has examined the possibility of developing
an anti-fescue-toxicosis vaccine. They have just received verbal communication
from Schering-Plough that they will fund their project to develop this method of
fescue toxicity control in cattle.

INFLAMMATION GROUP
Dr. Barry Rouse's laboratory is attempting to verify their hypothesis that
herpetic stromal keratitis, a common cause of ocular impairment, including
blindness, represents an inflammatory response by the host, within the eye, to
some components of the virus. They are seeking to establish the mechanisms of
this reaction and ultimately find some immunological means of controlling it.
Their recent results have provided further direct evidence that a single subset of T
lymphocytes, the CD4 + subset, are primarily involved in the immunopathology.
This was shown by transferring cells of known identity and reactivity into animals
whose own immune response had been compromised.
A second mission in Dr. Rouse's laboratory is involved with evaluating the
optimal means of inducing CD8 + T lymphocytes with soluble proteins and
nonreplicating viral antigens. They have used several approaches to this issue
including the demanding task of generating primary CD 8 + T cell mediated
cytotoxicity completely in vitro. They have achieved success finding that two

Programmatic Report

12

conditions are particularly important. These are the delivery of antigen within pH
sensitive liposomes and the use of a particular cell type, the dendritic cell, as a
means of delivering antigen.
Bacteria of the gram-negative type produce a toxin that is commonly
referred to as endotoxin. Because of its molecular structure, endotoxin is also
referred to as lipopolysaccharide, or simply LPS. In most cases, LPS does not act
directly on body tissues to cause sickness, but acts through the animal's own
immune system.
There is evidence that humans and some animals are stimulated to
synthesize a novel protein whenever they are exposed to the bacterial toxin LPS.
This protein is found circulating in the blood, and binds to the LPS molecule.
Because of this, it is called LPS-binding protein, or LBP. Once LBP and LPS are
bound, they attach to a receptor on cell surfaces called CD14. When this occurs,
the immune system becomes even more aware of the presence of the bacterial
toxin LPS. Although cattle are commonly afflicted by disease causing bacteria
that produce the LPS toxin, this important protein (LBP) and receptor (CD14) had
not been studied in cattle. The purpose of Dr. Philip Bochsler's work is to study
bovine LBP and CD 14 in order to better understand how bacterial LPS affects
cattle, which may ultimately contribute to improved treatment and control of
gram-negative bacterial infections of cattle.
Some of the work in Dr. David Slauson's laboratory is directly aimed at
major disease problems in livestock, including increased susceptibility of new born
calves to life-threatening bacterial infections and the mechanisms of signal

transduction in bovine leukocytes. In recent years, they have been -able to
document that leukocytes from new born calves exhibit marked functional
differences in respiratory burst activation, an important bactericidal system, as
well as in leukocyte membrane reactivity to complement stimulation. Dr. Slauson
has also been studying the transmembrane and intracellular signalling pathways
used by bacterial endotoxin in bovine lung macrophages.
Dr. Michael Breider has studied the effect of live and dead Pasteurella
haemolytica on bovine pulmonary endothelial cell (EC) monolayer cultures. He
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found the proliferation of live bacteria leads to severe EC toxicity and dead
bacteria can produce a similar EC toxicity, although a larger inoculating dose
must be given. The addition of polyclonal anti-£. haemolytica bovine serum and
neutrophils protect the EC from live £. haemolytica, but not dead £. haemolytica.
However, the addition of polymyxin B effectively protects EC, presumably by
neutralizing the bacterial endotoxin. These studies clearly demonstrate that
endotoxin is an important bacterial virulence factor, and the host defense system
of neutrophils and immune serum may protect against proliferation of P.
haemolytica in the lung but cannot protect against the endotoxin associated EC
damage.
l.D.6 Projects that Benefitted from COE Support
Dr. Erby Wilkinson has just received verbal notification that his grant

submissions to NIH titled Molecular Genetics of Polycystic Kidney Disease in the
Transgenic Tg737 Mouse and Immunobiology of the Scurfy Mouse have both been

funded to begin September 1, 1992. Both of these awards are a direct reflection
of COE start-up monies. Dr. Philip Bochsler's USDA grant titled Bovine
Lipopolysaccharide Binding Protein and Mechanisms of Macrophage Activation is a

result of starter monies from COE and Dr. David Dean's NIH Fellowship
application entitled Signalling Pathways in LPS-stimulated Lung Macrophages which
was funded was strengthened because of COE support.
Additionally, several projects supported in part by COE have resulted in
patents. Dr. Jack Oliver has received a patent, "Development of an Anti-Fescue
Toxicosis Vaccine" issued by the U. S. Patent Office on 1/21/92, U. S. Patent
Office #07/823, 146, UT Research Corporation File No. 91-16, and applied
February, 1992, for a second patent "Biomedical Use of Loline Alkaloids," UT
Research Corporation File No. 92-11. Dr. Hugo Eiler received a patent for
"Method for Treatment of Bovine Retained Placenta," U. S. Patent No. 5,089,264,
UT Research Corporation File No. PD 89-44 issued on February 18, 1992.
New faculty who have just been awarded startup funds from COE to
enhance extramural opportunities are:

Programmatic Report

14

•

Dr. Kevin Hahn, an assistant professor with joint appointments in
Environmental Practice and Urban Practice, is involved in both
basic and clinical oncology research. He is collaborating with Drs.
Donita Frazier and Masoud Panjehpour to determine what
treatment schemes induce the most sub-lethal DNA damage in
surviving tumor cells. Their long-term objective of this research is
to enhance tumor control.

•

The development of in vitro models of central nervous system
disorders or toxicities is of increasing importance both as screening
and mechanistic tools. Free radicals, such as oxygen centered
radicals, have been implicated in aging, which has special relevance
in the central nervous system in investigations of senile dementias.
Dr. Teresa Rowles is currently evaluating several neural cell lines of
human origin. Such determinations will be useful in future grant
applications for mechanistic and screening studies in the areas of
ischemia/reperfusion and neurotoxicities.

•

The Leydig cell produces the steroid testosterone in mammals.
Testosterone is required for the development and function of the
male reproductive tract. Dr. Charmi Mendis-Handagama will
attempt to identify whether peroxisomes are involved in the
transport and metabolism of cholesterol during steroidogenesis in
Leydig cells, and study the mechanisms involved in biogenesis of
peroxisomes in Leydig cells in response to LH stimulation.

•

Dr. Linda Bravo, a 2nd-year Resident in the Department of Urban
Practice is being funded by COE for a project entitled Serum
Cytokine Concentrations in Normal Dogs and in Dogs with Lymphoma
before and after Chemotherapy. Collaborating with Dr. Clinton
Lothrop, Auburn University, Dr. Kevin Hahn, Departments of
Environmental and Urban Practice, and The Thompson Cancer
Survival Center, they will seek to determine the appropriate levels
of recombinant cytokines to use in dogs post chemotherapeutic
treatment.

TABLE 1. CENTER OF EXCELLENCE IN LIVESTOCK DISEASES AND HUMAN HEALTH
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Benchmarks

The University of Tennessee
College of Veterinary Medicine
RESEARCH PROJECTS FUNDED EXTERNALLY
REPORT PERIOD 1991-92

TOTAL AMOUNT
AWARDED

ESTIMATED
EXPENDITURES
7-1-91 /6-30-92

PROJECT DIRECTOR

SOURCE

BOCHSLER, P. N.
J. M. Maddux & M. A. Breider
co-investigators
Bovine Lipopolysaccharide Binding
Protein and Mechanisms of Macrophage
Activation

USDA Competitive
9/1/91-8/31/93

140,000

59,970

BREIDER, M. A.
Effects of Pasteurella
haemo/vtica Pathogenic Factors
on Bovine Pulmonary Endothelium

USDA Special
9/15/87-9/30/90
(Extension to 9/30/91)

146,616

2,000

BRIAN, D. A.
Corona virus Structure and
Replication

NIH
9/1/89-8/31/94

565,311

94,080

DAWSON, D. A.
Joint Action of Developmental
Toxicants

Society of Toxicology /
U.S. Air Force
7/1/89-7/6/91

80,750

654

DAWSON, D. A.
SCHULTZ, T. W., Co-investigator
Mixture Teratogenesis: Relation
to Mechanisms and QSARs

NIEHS/NIH
4/1/91-3/31/93

138,043

68,472

DEAN, D.
(Research Fellowship)
Signalling Pathways in LPSStimulated Lung Macrophages

NIH Training Grant
11/30/91-11/30/94

97,500

18,200

GODKIN, J. &
Baumbach, G. A., Co-investigator
Bovine Fetal-Maternal
Interactions

USDA Competitive
9/1/88-8/31/91

237,000

13,166

LOTHROP, C. D.
The Molecular Biology of
Cyclic Hematopoiesis

NIH
12/1/88-11/30/93

862,438

151,488

LOTHROP, C. D.
Animal Models of Human Gene
Therapy

Mathers Charitable
Foundation
1/1/87-12/31/91

179,100

17,910
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PROJECT DIRECTOR

SOURCE

TOTAL AMOUNT
AWARDED

ESTIMATED
EXPENDITURES

7-1-91 /6-30-92
McDONALD, T. P.
Contract--Development of Assays
for Thrombopoietin

Genentech

178,732

33,000

3/1/88-2/28/93

Performance of Assays for
Thrombopoietin

3/1/88-7/31/93

112,700

20,808

MCDONALD, T. P.

NIH

548,681

115,600

Thrombopoietin: Immuno
assay & Characterization

12/1/88-11/30/93

McDONALD, T. P.
Purchase of: Cell Harvester
System

NHLSI Small
Instrumentation Program

8,253

8,253

2,844

1,896

125,000

10,416

57,752

14,438

25,576

12,788

98,388

49,194

31 ,778

8,664

6,293

1,992

75,000

24,996

149,200

8,386

L.
Effects of Progestagen Contraceptives
on the Uterus & Mammary Glands of
Exotic Felids
MUNSON,

J. W.
Toxic Fescue Alkoloid Effects
on Catecholamine Receptors in
Bovine
OLIVER,

9/1/91-8/31/92
Nixon Griffis Fund
(New York Zoological Soc.)

3/1/91-2/28/92

USDA Special Grant

9/1/89-8/31/91

OLIVER, S. P.
Mastitis Research

Alcide Corporation

OLIVER, S. P.
Mastitis Research

Monsanto Agri Co.

OLIVER, S. P.
Factors Influencing Bovine
Mononuclear Cell Function during
the Nonlactating Period
OLIVER, S. P.
Mastitis Research
OLIVER, S. P.
Mastitis Research
POTGIETER,

L.

12/90-12/94

11/90-12/92
USDA-SEA

9/90-9/92

H. S. Fuller Co.

4/91-12/94
Upjohn Company

10/91-12/94
Upjohn Company

Development of Technology for
use in the Discovery and
Production of a Commercial BVD
Vaccine and Diagnostic

2/1/90-12/31/92

L.
Genetic Organization of a
Pneumopathic Strain of Bovine
Viral Diarrhea Virus

USDA Special
Grant

POTGIETER,

9/1/88-8/31/91
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TOTAL AMOUNT
AWARDED

ESTIMATED
EXPENDITURES
7-1-91/6-30-92

PROJECT DIRECTOR

SOURCE

POTGIETER, L.
Cloning and Sequencing of BRSV
G Glycoprotein and Detection
of Strain Divergence

USDA Special
Grant
8/1/90-7/31/93

149,974

50,679

ROUSE, B. T.
Immunity Mechanisms in
Herpesvirus Infections

NIH
5/1/89-4/30/94

1,130,370

225,082

ROUSE, B. T.
Keratitis Treatment with Drugcontaining Immunoliposomes

National Eye
Institute (NIH)
9/30/87-9/29/92

708,050

153,519

ROUSE, B. T.
Liposome Microencapsulation
of Vaccine Antigens

NIAID
6/1/90-5/1/95

828,289

156,833

ROUSE, B. T.
Herpes Zosterification

SmithKline Biologicals
12/15/89-12/31/94

124,746

24,948

SCHULLER, H. M.
Transplacental
Carcinogenicity of NNK

NIH
9/1/89-11/30/92

491,219

161,316

SCHULLER, H. M.
Mechanisms of Neuroendocrine
Lung Carcinogenesis by
Nitrosamines

Shannon Award
(NIH)
9/1/91-8/31/93

100,000

41,670

SCHULLER, H. M.
Characterization of Induced
Neuroendocrine Lung Cancer

National Cancer
Institute (NIH)
7/1/88-6/30/91
(Extension to 12/31/92)

437,299

1,653

Characterization of Induced
Neuroendocrine Lung Cancer

National Cancer
Institute (NIH)
2/7/92-1/31/95

409,781

75,380

SCHULLER, H. M.
Contract--Testing of Anticarcinogenic Effects of
Niguldipine

Byk Gulden
Pharmaceuticals
3/1/88-10/31/93

183,000

32,292

SCHULLER, H. M.
Air Pollutants and
Neuroendocrine Lung Cancer

EPA
1/1/89-6/30/90
(Extension to 8/31/91)

98,104

6,132

SCHULTZ, T. W. &
Kot, Mark, Co-investigator
Chaos in Microbial Systems

NSF
12/1/89-11/30/92

111,615

56,659

SHULL, R.
Molecular Study of MPS I:
Gene Therapy in a Canine Model

NIH
8/1/87-7/31/92

1,105,183

107,510
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PROJECT DIRECTOR

SOURCE

SLAUSON, D. O. &
BOCHSLER, P. N., Co-investigator
Leukocyte Function and Host
Defense in Developing Calves

USDA Competitive
9/15/90-9/30/92

SLAUSON, D. O.

USDA Special
9/1/90-8/31/91
(Tranfer from Cornell)

Equine Endotoxemia: An in vitro
Model of Endotoxin-mediated Disease

WILKINSON, J. E.
MUNSON, L., Co-investigator
Role of TGF on Bovine Placental
Growth and Development

USDA Competitive
8/1/89-7/31/91

WILKINSON, J. E.
LOTHROP, C. D., Co-investigator
Development of Methods for
Therapeutic Gene Transfer in Dogs

AVMA Foundation
8/1/89-7/31/91
(Extension to 12/31/92)

WILKINSON, J. E. &
GODKIN, J. , Co-investigator
Transforming Growth Factors in
Early Pregnancy in the Cow

USDA Special
7/1/89-6/30/92

GRAND TOTAL

TOTAL AMOUNT
AWARDED

ESTIMATED
EXPENDITURES
7-1-91/6-30-92

120,000

60,000

64,175

10,695

160,000

6,667

13,895

4,068

149,653

49,884

11,991,358

•

I

j

,

I

I

\,

'.

PLANS 'FOR NEXT

,

Y,

YEAR ',

'

•

\

<

!.

'

I



"

,

'

Plans for Next Year

21

III. PLANS FOR NEXT YEAR

With the acquisition of an Assistant Dean for Research and Graduate Programs,
the college will be embarking on an era of renewed emphasis on scholarship.
Responsibilities of the Assistant Dean will include coordinating all research and graduate
study activities of the college. This position will enhance the college's visibility and
strengthen its competitiveness in research and provide assistance in the day-to-day
functioning of the Center.
More directed focus will be given the collaborative graduate program with UT
Memphis under the direction of David M. Renquist, DVM, MS, Chairman, Department
of Comparative Medicine, UT Memphis. Specific bylaws will be constituted, followed by
a formal enactment by the Graduate Council. An adjunct appointment with
veterinarians at St. Jude Children's Research Hospital will be activated relating to course
work, teaching, and training requirements. As proposed, approximately one half of the
trainee's time will be devoted to residency training in laboratory animal science and
medicine consisting primarily of participation in clinical rotations, weekly pathology
conferences, and participating in teaching programs and seminars on topics related to
laboratory animal science and medicine. Trainees will be involved in all aspects of the
clinical care program, and will learn to conduct all procedures carried out in the
diagnostic laboratory. Another important aspect of the training program will be the
study of animal models for medical research. The remaining half of the trainee's time
will be devoted to research training offered through one of the basic medical science
divisions. Students will attend research seminars sponsored by various university
research departments.
Previously Biomedical Research Support Grant (BRSG) funds were received
independently by the College of Veterinary Medicine and the Office of Research. The
College of Veterinary Medicine and the Biomedical Science Departments in the College
of Liberal Arts have agreed to cooperate in submitting a single proposal for BRSG
funds. With this change in scope of "venture" applications, young and new faculty in the
College of Veterinary Medicine will make application for BRSG funds through The
University of Tennessee-Knoxville. Targeted areas most likely to receive funding are:
(1) pilot research projects that show significant promise of leading to grant support from

Plans for Next Year

22

NIH or some other funding agency; (2) new investigators will be given highest priority,
but will be strongest when they show significant promise of achieving grant support from
NIH or some other agency; and (3) unexpected needs for projects currently supported by
NIH. These are proposals whereby funded investigators are experiencing unanticipated
needs requiring urgent attention. The University of Tennessee will request a 1:1 match
for BRSG funds.
The External Advisory Committee will arrive in late October or early November
for a site visit. Suggestions from the November 8, 1990, site visit have been
implemented. It was suggested by the committee to support a "limited number" of
programs. While the college originally focused on three program groups: Growth
Factors, Inflammation, and Oncology groups, the External Advisory Committee
recommended the formation of a fourth group, to be "broadly labelled an Environmental
Studies and Livestock Diseases Group." The Infectious Diseases and Population
Medicine group was established. An Internal Advisory Committee, under the direction
of the Assistant Director of COE, was also instituted and is now in its second year of
"advising the Director on the Center's program coordination and planning (goals)." The
External Advisory Committee has been instrumental in the implementation of major
goals and objectives of the college. The external review process will continue. However,
the review team will undergo a reorganization as Dr. Henry Baker and Dr. Peter
Doherty will rotate off.
One of our major goals for next year is to strengthen research ties with ORNL.
Dr. David Slauson will take the lead in these endeavors. Dr. Erby Wilkinson's two new
grants from NIH will directly enhance our link with the Biology Division, ORNL. Drs.
Virginia Godfrey and Laine Russell, of the Biology Division of ORNL, will be examining
the role of the thymus and thymic cell components in scurfy induction in mice.
In a second project, Dr. Wilkinson, along with Dr. Richard Woychik of the
Biology Division of ORNL will be seeking to characterize the phenotype of the Tg737
mouse including the clinical, pathologic, and clinicopathologic changes associated with
PKD.
A second major goal for next year is to broaden our oncology program. To that
end, in an effort to strengthen ties with The Thompson Cancer Survival Center and in
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collaboration with Dr. Donita Frazier, Dr. Michael Breider will make a transition from
the Inflammation Group to the Oncology Group. Currently they are investigating the
expression of angiogenic cytokines in several human tumor cell lines and have
successfully demonstrated basic fibroblast growth factor in a squamous cell carcinoma
line using Western blot techniques. They are also investigating photodynamic drug
uptake by endothelial cells and methods to enhance drug uptake by the cells. Dr. Kevin
Hahn has been brought into the group to provide the link between the clinical sciences
and basic sciences.
In addition, we plan to strengthen our Growth Factors Group with the addition to
the Center of Dr. Charmi Mendis-Handagama. Similarly, the Oncology and Toxicology
Group will be broadened with the addition of Dr. Teresa Rowles and her expertise in
neurotoxicity.
If Dr. Hildegard Schuller's Program Project Grant entitled "Signal Transduction as
a Target of Lung Cancer Therapy" is awarded, it will enhance our status in expanding the

Center's emphasis in Oncology and interinstitutional cooperative research. Project
leaders from outside the UT system are:
•

Dr. Kenneth L. Becker, project leader of the project "Modulation of
Neuroendocrine Markers in Lung Tumors" will be directing the research
effort from The George Washington University, Washington, D.C. (work
will take place off-campus at the VA Medical Center).

•

Dr. Andre Castonguay, project leader of the project "Effects of B859-35 on
Carcinogen Activation" will be directing the research effort for Laval
University, Quebec, Canada.

•

Dr. Paul Bunn, project leader of the project "Clinical Investigations" will be
directing the research effort for the University of Colorado, -Denver,
Colorado.
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Projects carried out within the college will be:
•
•
•
•

Regulation of Lung Cancer Mitrogenesis by Receptors, Project Leader Dr.
Hildegard Schuller
Second Messenger Pathways in Lung Cancer Cells, Project Leader Dr.
David Slauson
Molecular Biology of Lung Tumors, Project Leader Dr. Mark Miller
Electron Microscopy of Lung Tumor Cells, Project Leader Dr. Don
McGavin

The COE continues to be a strong influence and major support for many research
programs in the CVM. The democratic manner in which funds are allocated for support
of proposals underscores the spirit of cooperation and emphasizes the principle of shared
resources. Funds for the COE are an example of a good investment in the future of
Tennessee--minimal funds with maximum benefits.

Continued support for our expanding research endeavors is essential.
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SCHEDULE 1
CENTERS OF EXCELLENCE
ACTUAL, PROPOSED, AND REQUESTED BUDGET
College of Veterinary Medicine

Institution
Center

Livestock Diseases & Human Health
1992-93 Proposed Budget

1991-92 Actual Budget
Matching

Appropriations

Total

Matching

Appropriations

1993-94 Requested Budget
Total

Matching

Appropriations

Total

levenue
lew State Appropriation
:arryover State Appropriation
lew Matching Funds
:arryover from Previous Matchin
Total

517,900

517,900

2,422

2,422

258,950

258,950

821

821

506,500
253,250

506,500

532,000

253,250

266,000

532,000
266,000

259,771

520,322

780,093

253,250

506,500

759,750

266,000

532,000

798,000

51,085

102,323

153,408

36,877

73,865

1l0,742

33,400

66,600

100,000

54,891
25,307
7,99j
3,05
142,335

109,947
50,691
1~,~22
, 15
285,098

164,838
75'6 98
24
21
427,433

55,250
22,568
1,340
8,000
124,035

1l0,670
45,203
2,687
16,000
248,425

165,920
67,771
4,027
24,000
372,460

55,417
22,712
§,43~
,01
125,975

1l0,503
45,288
12,~2R
15,
8
251,195

165,920
68,000
21~,258
,00
377,170

27,541

55,163

82,704

32,245

64,595

96,840

30,660

61,140

91,800

169,876

340,261

510,l37

156,280

3l3,020

469,300

156,635

312,335

468,970

242
284

488
570

730
854

1,665

5,000

300

700

1,000

41,983
41,546
5,840

84,090
83,213
11,700

126,073
124,759
17,540

41,355
49,950
4,000

82,095
100,050
8,000

123,450
150,000
12,000

44,432
58,450
6,183

88,598
116,550
l3,817

l33,030
175,000
20,000

259,771

520,322

780,093

253,250

506,500

759,750

266,000

532,OCO

798,000
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CURRICULUM VITAE
S. M. LILITHA CHAMINDRANI MENDIS-HANDAGAMA
Education:
Degree
Monash University Melbourne, Australia. PhD.

Year
1985

Field of Study
Reproductive Biology.

University of Sri Lanka, Peradeniya.

1977

Vet. Med. & Surgery.

DVM.

The Johns Hopkins University, Baltimore. -postdoctoral training- Reproductive Biology.
Career History: Assistant Professor, Department of Animal Science, The University of Tennessee,
1991-present; Research Associate, Department of Population Dynamics, The Johns Hopkins
University, 1990-1991; Postdoctoral Fellow, The Johns Hopkins University, 1985-1989;
Research Assistant, Monash University, Australia, 1984-1985; Doctoral Student, Monash
University, Australia, 1980-1984; Lecturer, Department of Veterinary Pre-Clinical Studies,
University of Srilanka, 1977-1980.

Honors and Awards: Recipient of 1992 Idea Grant, Awarded by the Institute of Agriculture, UT;
recipient of Participation Award for 8IeSS awarded by the March of Dimes Organization, 1991;
Institutional Scholarship, awarded by The Johns Hopkins University, 1985-1989; Postdoctoral
Fellowship, awarded by the Mellon Foundation, 1986-1987; recipient of Hans Elias Award for
Distinguished Young Stereologists, awarded by the International Society for Stereology, 1987;
Trainee Travel Award, awarded by the Society for the Study of Reproduction, 1987; Postdoctoral
Fellowship, awarded by the Hewlett Foundation, 1985-1988; Monash Graduate Scholarship,
awarded by the Monash University, 1983-1984; Postgraduate Research Scholarship, awarded by
the World Health Organization, Switzerland, 1980~1983; Commonwealth Bureau of Animal
Health Award, awarded by the Commonwealth Bureau of Animal Health, England, 1975.
Invited Speaker in International Conferences: M.C. Chang Memorial Conference, Barcelona,
Spain, 1992.
TournaI Reviews: Journal of Andrology, Biology of Reproduction, Molecular & Cellular
Endocrinology.
Publications (Last 5 years):
1.

Mendis, S.M.L.C. (1985). Studies on Leydig cells: their development, heterogeneity and
response to tubule damage. Ph.D. Thesis. Monash University, Melbourne, Australia.

2.

Mendis-Handagama, S.M.L.C., Risbridger, G.P., de Kretser, D.M. (1987). Morphometric
analysis of the components of the neonatal and adult rat testis interstitium. Int. J. Andro1.
10:525-534.

3.

Hardy, M.P., Mendis-Handagama, S.M.L.C., Zirkin, B.R., Ewing, L.L. (1987).
Photoperiodic variation of Leydig cell numbers in the testis of the golden hamster: a
possible mechanism for their renewal during recrudescence. J. Exp. Zoo1. 244:269-276.

S.M.L.C. Mendis-Handagama
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4.

Mendis-Handagama, S.M.L.C., Zirkin, B.R., Ewing, L.L. (1988). Comparison of
components of the testis interstitium with testosterone secretion in hamster, rat and
guinea pig testes perfused in vitro. Am.J.Anat. 181:12-22.

5.

Walters, J.R., Juniewicz, P.E., Oesterling, J., Mendis-Handagama, S.M.L.C., Zirkin, B.R.,
Ewing, L.L. (1988). The effect of inhibition of aromatase enzyme activity on Leydig cell
structure and function in beagles. Endocrinology 123:2223-2229

6.

Keeney, D.S., Mendis-Handagama, S.M.L.C., Zirkin, B.R., Ewing, L.L. (1988). Effect of
long-term deprivation of luteinizing hormone on Leydig cell volume, Leydig cell number
and steroidogenic capacity of the rat testis. Endocrinology 123:2906-2915

7.

Mendis-Handagama, S.M.L.C., Hardy, M.P., Keeney, 0.5., Ewing, L.L. (1989).
Application of the disector method to enumerate cells in the testis. In: Regulation of
testicular function: signaling molecules and cell-cell communication, L.L. Ewing and B.
Robaire (ed), The New York Academy of Sciences, NY (Publisher), 564:86-98.

8.

Mendis-Handagama, S.M.L.C., Ewing, L.L. (1990). Sources of error in the estimation of
Leydig cell numbers in control and atrophied mammalian testes. J. Microscop. (Oxford)
159:73-82.

9.

Mendis-Handagama, S.M.L.C., Zirkin, B.R., Scallen, T. J., Ewing L.L. (1990). Studies on
peroxisomes of the adult rat Leydig cell. J. Andrology 11:270-278.

10.

Mendis-Handagama, S.M.L.C., Kerr, J.B., de Kretser, D.M. (1990). Experimental
cryptorchidism in the adult mouse I. Qualitative and quantitative light microscopic
morphology. J.Andrology 11:539-547.

11.

Mendis-Handagama, S.M.L.C., Kerr, J.B., de Kretser, D.M. (1990). Experimental
cryptorchidism in the adult mouse II. A hormonal study. J. Andrology 11:548-554.

12.

Mendis-Handagama, S.M.L.C., Watkins, P.A, Gelber, S.J, Scallen, T.J., Ewing L.L. (1990).
Luteinizing hormone causes rapid and transient increase in Leydig cell peroxisome
volume and its sterol carrier protein-2 content. Endocrinology 127:2947-2954.

13.
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